Cargando…
Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer
BACKGROUND: Ovarian cancer (OC) ranks fifth as a cause of gynecological cancer-associated death globally. Until now, the molecular mechanisms underlying the tumorigenesis and prognosis of OC have not been fully understood. This study aims to identify hub genes and therapeutic drugs involved in OC. M...
Autores principales: | Yang, Dan, He, Yang, Wu, Bo, Deng, Yan, Wang, Nan, Li, Menglin, Liu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6986075/ https://www.ncbi.nlm.nih.gov/pubmed/31987036 http://dx.doi.org/10.1186/s13048-020-0613-2 |
Ejemplares similares
-
Integrated Bioinformatics Analysis for the Screening of Hub Genes and Therapeutic Drugs in Androgen Receptor-Positive TNBC
por: Guo, Qiaonan, et al.
Publicado: (2022) -
Integrated Bioinformatics Analysis to Screen Hub Gene Signatures for Fetal Growth Restriction
por: Yang, Jingjin, et al.
Publicado: (2023) -
Identification of hub genes and therapeutic drugs in esophageal squamous cell carcinoma based on integrated bioinformatics strategy
por: Yang, Wanli, et al.
Publicado: (2019) -
Identification of Hub Genes in Colorectal Adenocarcinoma by Integrated Bioinformatics
por: Liu, Yang, et al.
Publicado: (2022) -
Integrated Bioinformatics Analysis for Identification of the Hub Genes Linked with Prognosis of Ovarian Cancer Patients
por: Li, Xiaofeng, et al.
Publicado: (2022)